Myasthenia gravis, AChR antibody positive (Q88659): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 15:00, 15 August 2026
Acetylcholine receptor (AChR) positive Myasthenia Gravis (MG) is the most prevalent type of MG. The antibodies are directed against postsynaptic proteins, usually the nicotinic acetylcholine receptor, making up 80% of all generalised MG patients. Fluctuating weakness increasing with repeated activity and improving after a period of rest is the characteristic hallmark. Half of the ocular MG patients (manifesting with fluctuating ptosis and diplopia) are AChR positive. 90% of early-onset (<40-50 years) generalised MG patients, typically females, are positive for AChR antibodies and usually have thymus hyperplasia. Most late-onset patients (either male or female) are also AChR positive and have atrophic thymuses.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_353120348 |
||
| English | Myasthenia gravis, AChR antibody positive |
Acetylcholine receptor (AChR) positive Myasthenia Gravis (MG) is the most prevalent type of MG. The antibodies are directed against postsynaptic proteins, usually the nicotinic acetylcholine receptor, making up 80% of all generalised MG patients. Fluctuating weakness increasing with repeated activity and improving after a period of rest is the characteristic hallmark. Half of the ocular MG patients (manifesting with fluctuating ptosis and diplopia) are AChR positive. 90% of early-onset (<40-50 years) generalised MG patients, typically females, are positive for AChR antibodies and usually have thymus hyperplasia. Most late-onset patients (either male or female) are also AChR positive and have atrophic thymuses. |
Statements
CID11:ID_353120348
0 references
dki-india-ID_353120348
0 references
Concluído
0 references
13 August 2026
0 references
